company-logo

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Pasithea Therapeutics Dividend Announcement

Pasithea Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Pasithea Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Pasithea Therapeutics Dividend History

Pasithea Therapeutics Dividend Yield

Pasithea Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Pasithea Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Pasithea Therapeutics Financial Ratios

P/E ratio-0.00
PEG ratio-0.00
P/B ratio0.18
ROE-15595.10%
Payout ratio-11.94%
Current ratio14.81
Quick ratio14.81
Cash Ratio0.01

Pasithea Therapeutics Dividend FAQ

Does Pasithea Therapeutics stock pay dividends?
Pasithea Therapeutics does not currently pay dividends to its shareholders.
Has Pasithea Therapeutics ever paid a dividend?
No, Pasithea Therapeutics has no a history of paying dividends to its shareholders. Pasithea Therapeutics is not known for its dividend payments.
Why doesn't Pasithea Therapeutics pay dividends?
There are several potential reasons why Pasithea Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Pasithea Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Pasithea Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Pasithea Therapeutics a dividend aristocrat?
Pasithea Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Pasithea Therapeutics a dividend king?
Pasithea Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Pasithea Therapeutics a dividend stock?
No, Pasithea Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Pasithea Therapeutics stocks?
To buy Pasithea Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Pasithea Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.